查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1611566

心律調節器市場規模、佔有率和趨勢分析報告：2025-2030 年按產品、應用、最終用途、地區和細分市場進行的預測

Pacemaker Market Size, Share & Trends Analysis Report By Product (External, Implantable), By Application (Arrhythmias, Congestive Heart Failure), By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 165 Pages | 商品交期: 2-10個工作天內

價格

心律調節器市場成長和趨勢

Grand View Research, Inc. 的最新報告顯示，到 2030 年，全球心律調節器市場規模預計將達到 77 億美元。

預計2025年至2030年該市場將以5.7%的複合年成長率成長。由於醫療技術的進步和全球對心律管理解決方案的需求不斷增加，該市場正在經歷穩定成長。無導線心律調節器、設備小型化和延長電池壽命等技術創新大大提高了心律調節器植入的有效性和便利性。整合遠端監控功能還允許醫療保健提供者遠端追蹤心律調節器功能和患者健康狀況，從而減少醫院就診次數，從而改善患者護理。 2024年11月，歐洲首例單室無線心臟心律調節器植入手術在伯恩大學醫院進行。這項手術由阿拉伯聯合大公國專家主導，證實了該國作為醫療創新領導者的地位及其對培養區域醫療專業人員的承諾。

市場受益於對治療心搏過緩、心律不整和心臟衰竭等心臟疾病的日益關注。由於心血管疾病仍然是全球死亡的主要原因之一，因此對可靠、有效的起搏裝置的需求不斷成長。心律調節器越來越被視為改善患者治療效果的重要解決方案，並在醫院和門診中心廣泛採用。由於心律調節器技術的不斷進步和心臟治療需求的不斷增加，預計未來幾年市場將保持強勁成長。 2023 年 11 月，MedStar 華盛頓醫院中心成為美國首批為心率異常緩慢的患者提供 Aveir DR無導線心律調節器系統的機構之一。

心律調節器市場報告亮點

  • 植入式心律調節器在產品類型佔據主導地位，2024年將佔據68.0%的市場佔有率，因為它們已被證明可有效治療心律不整，並廣泛應用於臨床實踐。
  • 2024年，由於心搏過緩過緩的盛行率很高，特別是在老年族群中，心搏過緩領域在應用中佔據了27.5%的顯著佔有率。
  • 從最終用途來看，由於醫院環境中提供先進的醫療基礎設施和專業護理，醫院細分市場將在 2024 年佔據主導地位。由於擴大採用微創手術和更快的恢復時間，門診病人設施預計將以最快的複合年成長率成長。
  • 由於先進的醫療基礎設施、高昂的醫療成本以及較早採用創新心律調節器技術，北美佔據了全球市場的最大佔有率，達到 43.4%。
  • 由於心血管疾病盛行率上升、醫療保健服務的改善以及該地區醫療保健投資的增加，預計亞太地區在預測期內將以最快的複合年成長率成長。
  • 競爭的特點是主要企業實施產品發布、分銷協議和戰略夥伴關係關係等策略，以顯著擴大市場佔有率。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章心律調節器市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 心律調節器市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章心律調節器市場：按產品分類的估計和趨勢分析

  • 全球心律調節器市場：產品儀表板
  • 全球心律調節器市場：產品波動分析
  • 2018-2030年全球心律調節器市場規模、預測及趨勢分析
  • 體外心律心律調節器
    • 單室
    • 雙腔室
  • 植入式心律調節器
    • 傳統的
    • 無引線

第5章心律調節器市場：按應用、估計和趨勢分析

  • 全球心律調節器市場：應用儀表板
  • 全球心律調節器市場：應用變化分析
  • 2018-2030年全球心律調節器市場規模、預測及趨勢分析
  • 心搏過緩
  • 急性心肌梗塞
  • 心律不整
    • 心房顫動
    • 心臟傳導阻滯
    • 長QT症候群
  • 鬱血性心臟衰竭
  • 其他

第6章心律調節器市場：最終用途的估計和趨勢分析

  • 全球心律調節器市場：最終用途儀表板
  • 全球心律調節器市場：最終用途變化分析
  • 2018-2030年全球心律調節器市場規模、預測及趨勢分析
  • 醫院
  • 門診設施

第7章心律調節器市場：按國家、產品、應用和最終用途進行的區域估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模及預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 主要製造商的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 2024年主要企業市場佔有率分析
  • 公司簡介
    • Osypka Medical GmbH
    • Zoll Medical Corporation
    • Medtronic
    • BIOTRONIK
    • MicroPort Scientific Corporation
    • MEDICO SpA
    • Pacetronix
    • Oscor Inc
    • Boston Scientific Corporation
    • Lepu Medical Technology（Beijing）Co., Ltd.
Product Code: GVR-1-68038-336-2

Pacemaker Market Growth & Trends:

The global pacemaker market size is expected to reach USD 7.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 5.7% from 2025 to 2030. The market is experiencing steady growth, driven by advancements in medical technology and an increasing global demand for heart rhythm management solutions. Technological innovations, such as leadless pacemakers, smaller devices, and improved battery life, have significantly enhanced the effectiveness and convenience of pacemaker implantation. Integrating remote monitoring capabilities has also improved patient care by allowing healthcare providers to track pacemaker function and patient health remotely, reducing hospital visits. In November 2024, Europe witnessed its first single-chamber, wireless cardiac pacemaker implantation at Bern University Hospital. This procedure, led by experts from the UAE, underscores the country's position as a leader in medical innovation and its commitment to training regional healthcare professionals.

The market benefits from a greater focus on treating heart conditions such as bradycardia, arrhythmias, and heart failure. As cardiovascular diseases remain one of the leading causes of death globally, the need for reliable and effective pacing devices continues to rise. Pacemakers are increasingly seen as a critical solution for improving patient outcomes, leading to their widespread adoption in hospitals and outpatient centers. With continuous advancements in pacemaker technology and a growing demand for cardiac care, the market is expected to maintain strong growth in the coming years. In November 2023, MedStar Washington Hospital Center became one of the first institutions in the U.S. to offer the Aveir DR Leadless Pacemaker System for patients with abnormally slow heart rates.

Pacemaker Market Report Highlights:

  • The implantable pacemaker segment dominated the product category in 2024 with 68.0% of the market share due to its proven effectiveness in treating heart rhythm disorders and widespread adoption in clinical practice.
  • In 2024, the bradycardia segment accounted for a substantial share of 27.5% by application owing to the high prevalence of bradycardia, particularly among aging populations.
  • In terms of end use, the hospital segment dominated in 2024 due to the advanced healthcare infrastructure and specialized care available in hospital settings. Outpatient facilities are anticipated to grow at the fastest CAGR owing to the increasing adoption of minimally invasive procedures and shorter recovery times.
  • North America held the largest share of 43.4% of the global market due to advanced healthcare infrastructure, high healthcare spending, and early adoption of innovative pacemaker technologies.
  • Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period due to rising cardiovascular disease prevalence, improving healthcare access, and increasing healthcare investments in the region.
  • The competition features key players implementing strategies like product launches, distribution agreements, and strategic partnerships, which have greatly expanded their market share.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
  • 2.3. Competitive Insights

Chapter 3. Pacemaker Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of cardiovascular diseases (CVD)
      • 3.2.1.2. Favorable reimbursement policies
      • 3.2.1.3. Technological advancements
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulation and approvals
      • 3.2.2.2. Product Recalls
  • 3.3. Pacemaker Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Pacemaker Market: Product Estimates & Trend Analysis

  • 4.1. Global Pacemaker Market: Product Dashboard
  • 4.2. Global Pacemaker Market: Product Movement Analysis
  • 4.3. Global Pacemaker Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 4.4. External Pacemakers
    • 4.4.1. External pacemakers market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.2. Single Chamber
      • 4.4.2.1. Single Chamber market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.3. Dual Chamber
      • 4.4.3.1. Dual Chamber market estimates and forecasts 2018 to 2030 (USD Billion)
  • 4.5. Implantable Pacemakers
    • 4.5.1. Implantable pacemakers market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.2. Conventional
      • 4.5.2.1. Conventional market estimates and forecasts 2018 to 2030 (USD Billion)
      • 4.5.2.2. Single Chamber
        • 4.5.2.2.1. Single Chamber market estimates and forecasts 2018 to 2030 (USD Billion)
      • 4.5.2.3. Dual Chamber
        • 4.5.2.3.1. Dual Chamber market estimates and forecasts 2018 to 2030 (USD Billion)
      • 4.5.2.4. Biventricular Chamber
        • 4.5.2.4.1. Biventricular Chamber market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.5.3. Leadless
      • 4.5.3.1. Leadless market estimates and forecasts 2018 to 2030 (USD Billion)
      • 4.5.3.2. Single Chamber
        • 4.5.3.2.1. Single Chamber market estimates and forecasts 2018 to 2030 (USD Billion)
      • 4.5.3.3. Dual Chamber
        • 4.5.3.3.1. Dual Chamber market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. Pacemaker Market: Application Estimates & Trend Analysis

  • 5.1. Global Pacemaker Market: Application Dashboard
  • 5.2. Global Pacemaker Market: Application Movement Analysis
  • 5.3. Global Pacemaker Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 5.4. Bradycardia
    • 5.4.1. Bradycardia market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.5. Acute Myocardial Infarction
    • 5.5.1. Acute myocardial infarction market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.6. Arrhythmias
    • 5.6.1. Arrhythmias market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.6.2. Atrial Fibrillation
      • 5.6.2.1. Atrial Fibrillation market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.6.3. Heart Block
      • 5.6.3.1. Heart Block market estimates and forecasts 2018 to 2030 (USD Billion)
    • 5.6.4. Long QT Syndrome
      • 5.6.4.1. Long QT syndrome market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.7. Congestive Heart Failure
    • 5.7.1. Congestive heart failure market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.8. Others
    • 5.8.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. Pacemaker Market: End Use Estimates & Trend Analysis

  • 6.1. Global Pacemaker Market: End Use Dashboard
  • 6.2. Global Pacemaker Market: End Use Movement Analysis
  • 6.3. Global Pacemaker Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 6.4. Hospitals
    • 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.5. Outpatient Facilities
    • 6.5.1. Outpatient Facilities market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 7. Cardiovascular Devices Market: Regional Estimates & Trend Analysis by Country, Product, Application, and End-use

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 8.2. Company/Competition Categorization
  • 8.3. Key company market share analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. Osypka Medical GmbH
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Zoll Medical Corporation
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Medtronic
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. BIOTRONIK
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. MicroPort Scientific Corporation
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. MEDICO SpA
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Pacetronix
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Oscor Inc
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Boston Scientific Corporation
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Lepu Medical Technology (Beijing) Co., Ltd.
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 Global Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 3 Global Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 4 Global Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 5 Global Pacemaker Market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America Pacemaker Market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 9 North America Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 11 U.S. Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 14 Canada Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 17 Mexico Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe Pacemaker Market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 21 Europe Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 22 Europe Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Germany Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 24 Germany Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 25 Germany Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 26 UK Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 27 UK Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 28 UK Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 30 France Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 31 France Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 33 Italy Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 36 Spain Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Denmark Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 39 Denmark Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 40 Denmark Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Sweden Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 42 Sweden Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 43 Sweden Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Norway Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 45 Norway Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 46 Norway Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Pacemaker Market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 51 China Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 52 China Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 53 China Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Japan Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 55 Japan Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 56 Japan Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 58 India Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 59 India Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 60 South Korea Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 61 South Korea Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 62 South Korea Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Australia Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 64 Australia Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 65 Australia Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Thailand Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 67 Thailand Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 68 Thailand Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America Pacemaker Market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 71 Latin America Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 72 Latin America Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 74 Brazil Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 77 Argentina Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 82 South Africa Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 83 South Africa Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 84 South Africa Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 88 UAE Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 89 UAE Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 90 UAE Pacemaker Market, by end use, 2018 - 2030 (USD Million)
  • Table 91 Kuwait Pacemaker Market, by product, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Pacemaker Market, by application, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Pacemaker Market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Pacemaker Market segmentation
  • Fig. 8 Market snapshot, 2024
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Global Pacemaker Market: Product Outlook Key Takeaways
  • Fig. 15 Global Pacemaker Market: Product Movement Analysis
  • Fig. 16 Global External Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 17 Global External Pacemakers Single Chamber Market, 2018 - 2030 (USD Million)
  • Fig. 18 Global External Pacemakers Dual Chamber Market, 2018 - 2030 (USD Million)
  • Fig. 19 Global Implantable Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 20 Global Implantable Pacemaker Conventional Market, 2018 - 2030 (USD Million)
  • Fig. 21 Global Implantable Pacemaker Conventional Single Chamber Market, 2018 - 2030 (USD Million)
  • Fig. 22 Global Implantable Pacemaker Conventional Dual Chamber Market, 2018 - 2030 (USD Million)
  • Fig. 23 Global Implantable Pacemaker Conventional Biventricular Chamber Market, 2018 - 2030 (USD Million)
  • Fig. 24 Global Implantable Pacemaker Leadless Market, 2018 - 2030 (USD Million)
  • Fig. 25 Global Implantable Pacemaker Leadless Single Chamber Market, 2018 - 2030 (USD Million)
  • Fig. 26 Global Implantable Pacemaker Leadless Dual Chamber Market, 2018 - 2030 (USD Million)
  • Fig. 27 Global Pacemaker Market: Application Outlook Key Takeaways
  • Fig. 28 Global Pacemaker Market: Application Movement Analysis
  • Fig. 29 Global Bradycardia Market, 2018 - 2030 (USD Million)
  • Fig. 30 Global Acute Myocardial Infarction Market, 2018 - 2030 (USD Million)
  • Fig. 31 Global Arrhythmias Market, 2018 - 2030 (USD Million)
  • Fig. 32 Global Atrial Fibrillation Market, 2018 - 2030 (USD Million)
  • Fig. 33 Global Heart Block Market, 2018 - 2030 (USD Million)
  • Fig. 34 Global Long QT Syndrome Market, 2018 - 2030 (USD Million)
  • Fig. 35 Global Congestive Heart Failure Market, 2018 - 2030 (USD Million)
  • Fig. 36 Global Others Market, 2018 - 2030 (USD Million)
  • Fig. 37 Global Pacemaker Market: End Use Outlook Key Takeaways
  • Fig. 38 Global Pacemaker Market: End Use Movement Analysis
  • Fig. 39 Global Hospitals Market, 2018 - 2030 (USD Million)
  • Fig. 40 Global Outpatient Facilities Market, 2018 - 2030 (USD Million)
  • Fig. 41 Regional Marketplace: Key Takeaways
  • Fig. 42 Regional outlook, 2024 & 2030
  • Fig. 43 Global Pacemaker Market: Region Movement Analysis
  • Fig. 44 North America Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 45 U.S. Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 46 Canada Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 47 Mexico Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 48 Europe Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 49 Germany Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 50 UK Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 51 France Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 52 Italy Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 53 Spain Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 54 Spain Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 55 Denmark Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 56 Sweden Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 57 Norway Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 58 Asia pacific Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 59 Japan Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 60 China Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 61 India Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 62 Australia Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 63 South Korea Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 64 Thailand Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 65 Latin America Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 66 Brazil Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 67 Argentina Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 68 Middle East and Africa Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 69 South Africa Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 70 Saudi Arabia Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 71 UAE Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 72 Kuwait Pacemaker Market, 2018 - 2030 (USD Million)
  • Fig. 73 Strategy framework